Biopharmaceutical companies

Clinical trials are at the centre of the development process for new drugs and improved therapies. Designing and managing these trials effectively from the outset is critical to the success of potential breakthrough products. This requires knowledge and expertise complemented by exceptional project management capability. We are particularly keen to facilitate research into orphan indications which are often overlooked and require specialist project oversight.

Medical device companies

Companies constantly strive to innovate and improve the delivery of healthcare through medical device advances. The last decade has led to the development of state-of-the-art medical devices and advancement in the healthcare industry. Changing EU regulations have significantly impacted clinical trials for device companies. Supporting this process with appropriate clinical trial design and implementation is a core part of the Afortiori offering and we have expertise across Class I, IIa, IIb, and III.

Wearable technology companies

Medical software, wearable technology and mobile technology all have the potential to revolutionise how we effectively manage health and wellness. This growing market has incredible potential to improve quality of life for everyone. There is an important opportunity for companies to provide evidence on the usability and benefits of these products through clinical trials. While some of this technology may not legally require clinical testing, we believe that there are significant advantages to providing evidence of benefit through the clinical trial process.

Foundations and patient groups

Many charities and not-for-profit organisations fund, drive and facilitate clinical research into new and improved treatments and therapies. They form a critical part of the research infrastructure and are often involved in priority setting partnerships with patients, carers and families. They are able to provide patient and public involvement in research design to ensure that clinical trials are likely to recruit and retain participants. We are committed to providing these groups with a research partnership driven by integrity where commercial considerations are not the driving force.

CRO partnerships

We have a presence in Ireland and the UK for existing clinical research organisations (CROs) currently without representation in this region. We will work with you to facilitate the full feasibility and successful execution of a trial, using our existing site relationships and knowledge of the local regulatory system. We can also link up with other clinical research service providers in other countries to offer you the widest possible scope.

Investment community

We understand that many of our smaller clients are funded by a range of individuals and organisations. The value of this investment is directly linked to the success of their client’s clinical development strategy. This is because the clinical development strategy will inform the right development and clinical trial pathway for that product. We work with investors to provide this service to their clients and mitigate risk in the long term.

Industry organisations

There are a range of organisations that exist to support many of our clients in the clinical development journey. We provide training and ad hoc advisory services in partnership with these organisations in support of our mission to improve the overall landscape for clinical trials.

Technology transfer offices

In addition to the investment community, our third level institutions also work with newly emerging spin out companies that require support in terms of clinical development strategies. Many of these very early stage companies require help in the determination of the right clinical development plan for their product created in partnership with experts. This means that their product is given a thorough review in terms of its potential/risks. This is the best start that any new company could wish for in the healthcare space.